Global Nucleic Acid Electrophoresis Market
Global Nucleic Acid Electrophoresis Market

Nucleic Acid Electrophoresis Comprehensive Study by Application (Research, Diagnostics), End Users (Research Institutes, Hospitals, Diagnostics Centre), Instrument (Horizontal Gel Electrophoresis Systems, Vertical Gel Electrophoresis Systems), Gel (Polyacrylamide Gel, Agarose Gel) Players and Region - Global Market Outlook to 2026

Nucleic Acid Electrophoresis Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026  

Oct 2021 Edition 204 Pages 218 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Industry Background:
Nucleic Acid Electrophoresis, is still a rapid and accessible technique for many diagnostic procedures, particularly in research centers or at point-of-care clinics. Using a UV-transilluminator or UV-photo documentation device, standard techniques detect DNA/RNA molecules through specific bonded chemical dyes. Using generally available parts and simple manufacturing procedures such as light-emitting diodes (LEDs) and 3D imprint, the suggested device investigates the visible light absorption range of routinely used DNA/RNA dyes. Our system uses IoT techniques to cover a broad colour spectrum in order to detect bands from a variety of commercially used dyes, and it uses Bluetooth connectivity and a smartphone for hardware control, image capture, and sharing.This growth is primarily driven by The Rise in the Number of Diagnostic, Forensics, and Research Institutes and Increased Use in DNA Analysis and Antibiotics Testing.

Globally, a noticeable market trend is evident Rapid Development of Electrophoresis in Vaccine for Covid19. Major Players, such as Thermo Fisher Scientific (United States), Bio-Rad Laboratories (United States), Merck Group (Germany), Agilent Technologies (United States), Danaher Corporation (United States), GE Healthcare (United States), QIAGEN N.V. (Netherlands), Harvard Bioscience (United States), Biomol GmbH (Germany) and Agilent Technologies (United States) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

Key Developments in the Market:
In June 2021 Thermo Fisher Scientific released a statement announcing the acquisition of Advanced Electrophoresis Solutions. The companies will work together to enhance Thermo Fisher's spectrometric knowledge and experience in biopharma and proteomics applications, as well as AES' ability to provide high-performance entire section image processing sensing capillary electrophoresis processes for separating proteins, quantification, and classification.

Market Drivers
  • The Rise in the Number of Diagnostic, Forensics, and Research Institutes
  • Increased Use in DNA Analysis and Antibiotics Testing

Market Trend
  • Rapid Development of Electrophoresis in Vaccine for Covid19

Restraints
  • Issues in Quality of Electrophoresis Results

Opportunities
Increased Incidence of Heart and Infectious Diseases
Challenges
If the Concentration Is Too High or Too Low, Mistakes in Resolving the Various Bands Will Occur

AMA Research follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.

Customization in the Report
AMA Research features not only specific market forecasts, but also include significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Nucleic Acid Electrophoresis Study Sheds Light on
— The Nucleic Acid Electrophoresis Market status quo and key characteristics. To end this, Analyst at AMA organize and took survey of the Nucleic Acid Electrophoresis industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Nucleic Acid Electrophoresis industry is heading and what are the top priorities. Insights are drawn from financial analysis, the survey and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold value they currently claim, or capture the new addressable opportunity.

Frequently Asked Questions (FAQ):

1. What are the years considered in the Nucleic Acid Electrophoresis Market?
Historical year: 2016-2020; Base year: 2020; Forecast period: 2021 to 2026

2. Who are the key players profiled in the Nucleic Acid Electrophoresis Market?
Companies that are profiled in Global Nucleic Acid Electrophoresis Market are Thermo Fisher Scientific (United States), Bio-Rad Laboratories (United States), Merck Group (Germany), Agilent Technologies (United States), Danaher Corporation (United States), GE Healthcare (United States), QIAGEN N.V. (Netherlands), Harvard Bioscience (United States), Biomol GmbH (Germany) and Agilent Technologies (United States) etc.

3. What is Nucleic Acid Electrophoresis Market?
Nucleic Acid Electrophoresis, is still a rapid and accessible technique for many diagnostic procedures, particularly in research centers or at point-of-care clinics. Using a UV-transilluminator or UV-photo documentation device, standard techniques detect DNA/RNA molecules through specific bonded chemical dyes. Using generally available parts and simple manufacturing procedures such as light-emitting diodes (LEDs) and 3D imprint, the suggested device investigates the visible light absorption range of routinely used DNA/RNA dyes. Our system uses IoT techniques to cover a broad colour spectrum in order to detect bands from a variety of commercially used dyes, and it uses Bluetooth connectivity and a smartphone for hardware control, image capture, and sharing.
Report Objectives / Segmentation Covered
By Application
  • Research
  • Diagnostics
By End Users
  • Research Institutes
  • Hospitals
  • Diagnostics Centre

By Instrument
  • Horizontal Gel Electrophoresis Systems
  • Vertical Gel Electrophoresis Systems

By Gel
  • Polyacrylamide Gel
  • Agarose Gel

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. The Rise in the Number of Diagnostic, Forensics, and Research Institutes
      • 3.2.2. Increased Use in DNA Analysis and Antibiotics Testing
    • 3.3. Market Challenges
      • 3.3.1. If the Concentration Is Too High or Too Low, Mistakes in Resolving the Various Bands Will Occur
    • 3.4. Market Trends
      • 3.4.1. Rapid Development of Electrophoresis in Vaccine for Covid19
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Nucleic Acid Electrophoresis, by Application, End Users, Instrument, Gel and Region (value and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Nucleic Acid Electrophoresis (Value)
      • 5.2.1. Global Nucleic Acid Electrophoresis by: Application (Value)
        • 5.2.1.1. Research
        • 5.2.1.2. Diagnostics
      • 5.2.2. Global Nucleic Acid Electrophoresis by: End Users (Value)
        • 5.2.2.1. Research Institutes
        • 5.2.2.2. Hospitals
        • 5.2.2.3. Diagnostics Centre
      • 5.2.3. Global Nucleic Acid Electrophoresis by: Instrument (Value)
        • 5.2.3.1. Horizontal Gel Electrophoresis Systems
        • 5.2.3.2. Vertical Gel Electrophoresis Systems
      • 5.2.4. Global Nucleic Acid Electrophoresis by: Gel (Value)
        • 5.2.4.1. Polyacrylamide Gel
        • 5.2.4.2. Agarose Gel
      • 5.2.5. Global Nucleic Acid Electrophoresis Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Nucleic Acid Electrophoresis (Price)
  • 6. Nucleic Acid Electrophoresis: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Thermo Fisher Scientific (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Bio-Rad Laboratories (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Merck Group (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Agilent Technologies (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Danaher Corporation (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. GE Healthcare (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. QIAGEN N.V. (Netherlands)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Harvard Bioscience (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Biomol GmbH (Germany)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Agilent Technologies (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Nucleic Acid Electrophoresis Sale, by Application, End Users, Instrument, Gel and Region (value and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Nucleic Acid Electrophoresis (Value)
      • 7.2.1. Global Nucleic Acid Electrophoresis by: Application (Value)
        • 7.2.1.1. Research
        • 7.2.1.2. Diagnostics
      • 7.2.2. Global Nucleic Acid Electrophoresis by: End Users (Value)
        • 7.2.2.1. Research Institutes
        • 7.2.2.2. Hospitals
        • 7.2.2.3. Diagnostics Centre
      • 7.2.3. Global Nucleic Acid Electrophoresis by: Instrument (Value)
        • 7.2.3.1. Horizontal Gel Electrophoresis Systems
        • 7.2.3.2. Vertical Gel Electrophoresis Systems
      • 7.2.4. Global Nucleic Acid Electrophoresis by: Gel (Value)
        • 7.2.4.1. Polyacrylamide Gel
        • 7.2.4.2. Agarose Gel
      • 7.2.5. Global Nucleic Acid Electrophoresis Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Nucleic Acid Electrophoresis (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Nucleic Acid Electrophoresis: by Application(USD Million)
  • Table 2. Nucleic Acid Electrophoresis Research , by Region USD Million (2015-2020)
  • Table 3. Nucleic Acid Electrophoresis Diagnostics , by Region USD Million (2015-2020)
  • Table 4. Nucleic Acid Electrophoresis: by End Users(USD Million)
  • Table 5. Nucleic Acid Electrophoresis Research Institutes , by Region USD Million (2015-2020)
  • Table 6. Nucleic Acid Electrophoresis Hospitals , by Region USD Million (2015-2020)
  • Table 7. Nucleic Acid Electrophoresis Diagnostics Centre , by Region USD Million (2015-2020)
  • Table 8. Nucleic Acid Electrophoresis: by Instrument(USD Million)
  • Table 9. Nucleic Acid Electrophoresis Horizontal Gel Electrophoresis Systems , by Region USD Million (2015-2020)
  • Table 10. Nucleic Acid Electrophoresis Vertical Gel Electrophoresis Systems , by Region USD Million (2015-2020)
  • Table 11. Nucleic Acid Electrophoresis: by Gel(USD Million)
  • Table 12. Nucleic Acid Electrophoresis Polyacrylamide Gel , by Region USD Million (2015-2020)
  • Table 13. Nucleic Acid Electrophoresis Agarose Gel , by Region USD Million (2015-2020)
  • Table 14. South America Nucleic Acid Electrophoresis, by Country USD Million (2015-2020)
  • Table 15. South America Nucleic Acid Electrophoresis, by Application USD Million (2015-2020)
  • Table 16. South America Nucleic Acid Electrophoresis, by End Users USD Million (2015-2020)
  • Table 17. South America Nucleic Acid Electrophoresis, by Instrument USD Million (2015-2020)
  • Table 18. South America Nucleic Acid Electrophoresis, by Gel USD Million (2015-2020)
  • Table 19. Brazil Nucleic Acid Electrophoresis, by Application USD Million (2015-2020)
  • Table 20. Brazil Nucleic Acid Electrophoresis, by End Users USD Million (2015-2020)
  • Table 21. Brazil Nucleic Acid Electrophoresis, by Instrument USD Million (2015-2020)
  • Table 22. Brazil Nucleic Acid Electrophoresis, by Gel USD Million (2015-2020)
  • Table 23. Argentina Nucleic Acid Electrophoresis, by Application USD Million (2015-2020)
  • Table 24. Argentina Nucleic Acid Electrophoresis, by End Users USD Million (2015-2020)
  • Table 25. Argentina Nucleic Acid Electrophoresis, by Instrument USD Million (2015-2020)
  • Table 26. Argentina Nucleic Acid Electrophoresis, by Gel USD Million (2015-2020)
  • Table 27. Rest of South America Nucleic Acid Electrophoresis, by Application USD Million (2015-2020)
  • Table 28. Rest of South America Nucleic Acid Electrophoresis, by End Users USD Million (2015-2020)
  • Table 29. Rest of South America Nucleic Acid Electrophoresis, by Instrument USD Million (2015-2020)
  • Table 30. Rest of South America Nucleic Acid Electrophoresis, by Gel USD Million (2015-2020)
  • Table 31. Asia Pacific Nucleic Acid Electrophoresis, by Country USD Million (2015-2020)
  • Table 32. Asia Pacific Nucleic Acid Electrophoresis, by Application USD Million (2015-2020)
  • Table 33. Asia Pacific Nucleic Acid Electrophoresis, by End Users USD Million (2015-2020)
  • Table 34. Asia Pacific Nucleic Acid Electrophoresis, by Instrument USD Million (2015-2020)
  • Table 35. Asia Pacific Nucleic Acid Electrophoresis, by Gel USD Million (2015-2020)
  • Table 36. China Nucleic Acid Electrophoresis, by Application USD Million (2015-2020)
  • Table 37. China Nucleic Acid Electrophoresis, by End Users USD Million (2015-2020)
  • Table 38. China Nucleic Acid Electrophoresis, by Instrument USD Million (2015-2020)
  • Table 39. China Nucleic Acid Electrophoresis, by Gel USD Million (2015-2020)
  • Table 40. Japan Nucleic Acid Electrophoresis, by Application USD Million (2015-2020)
  • Table 41. Japan Nucleic Acid Electrophoresis, by End Users USD Million (2015-2020)
  • Table 42. Japan Nucleic Acid Electrophoresis, by Instrument USD Million (2015-2020)
  • Table 43. Japan Nucleic Acid Electrophoresis, by Gel USD Million (2015-2020)
  • Table 44. India Nucleic Acid Electrophoresis, by Application USD Million (2015-2020)
  • Table 45. India Nucleic Acid Electrophoresis, by End Users USD Million (2015-2020)
  • Table 46. India Nucleic Acid Electrophoresis, by Instrument USD Million (2015-2020)
  • Table 47. India Nucleic Acid Electrophoresis, by Gel USD Million (2015-2020)
  • Table 48. South Korea Nucleic Acid Electrophoresis, by Application USD Million (2015-2020)
  • Table 49. South Korea Nucleic Acid Electrophoresis, by End Users USD Million (2015-2020)
  • Table 50. South Korea Nucleic Acid Electrophoresis, by Instrument USD Million (2015-2020)
  • Table 51. South Korea Nucleic Acid Electrophoresis, by Gel USD Million (2015-2020)
  • Table 52. Taiwan Nucleic Acid Electrophoresis, by Application USD Million (2015-2020)
  • Table 53. Taiwan Nucleic Acid Electrophoresis, by End Users USD Million (2015-2020)
  • Table 54. Taiwan Nucleic Acid Electrophoresis, by Instrument USD Million (2015-2020)
  • Table 55. Taiwan Nucleic Acid Electrophoresis, by Gel USD Million (2015-2020)
  • Table 56. Australia Nucleic Acid Electrophoresis, by Application USD Million (2015-2020)
  • Table 57. Australia Nucleic Acid Electrophoresis, by End Users USD Million (2015-2020)
  • Table 58. Australia Nucleic Acid Electrophoresis, by Instrument USD Million (2015-2020)
  • Table 59. Australia Nucleic Acid Electrophoresis, by Gel USD Million (2015-2020)
  • Table 60. Rest of Asia-Pacific Nucleic Acid Electrophoresis, by Application USD Million (2015-2020)
  • Table 61. Rest of Asia-Pacific Nucleic Acid Electrophoresis, by End Users USD Million (2015-2020)
  • Table 62. Rest of Asia-Pacific Nucleic Acid Electrophoresis, by Instrument USD Million (2015-2020)
  • Table 63. Rest of Asia-Pacific Nucleic Acid Electrophoresis, by Gel USD Million (2015-2020)
  • Table 64. Europe Nucleic Acid Electrophoresis, by Country USD Million (2015-2020)
  • Table 65. Europe Nucleic Acid Electrophoresis, by Application USD Million (2015-2020)
  • Table 66. Europe Nucleic Acid Electrophoresis, by End Users USD Million (2015-2020)
  • Table 67. Europe Nucleic Acid Electrophoresis, by Instrument USD Million (2015-2020)
  • Table 68. Europe Nucleic Acid Electrophoresis, by Gel USD Million (2015-2020)
  • Table 69. Germany Nucleic Acid Electrophoresis, by Application USD Million (2015-2020)
  • Table 70. Germany Nucleic Acid Electrophoresis, by End Users USD Million (2015-2020)
  • Table 71. Germany Nucleic Acid Electrophoresis, by Instrument USD Million (2015-2020)
  • Table 72. Germany Nucleic Acid Electrophoresis, by Gel USD Million (2015-2020)
  • Table 73. France Nucleic Acid Electrophoresis, by Application USD Million (2015-2020)
  • Table 74. France Nucleic Acid Electrophoresis, by End Users USD Million (2015-2020)
  • Table 75. France Nucleic Acid Electrophoresis, by Instrument USD Million (2015-2020)
  • Table 76. France Nucleic Acid Electrophoresis, by Gel USD Million (2015-2020)
  • Table 77. Italy Nucleic Acid Electrophoresis, by Application USD Million (2015-2020)
  • Table 78. Italy Nucleic Acid Electrophoresis, by End Users USD Million (2015-2020)
  • Table 79. Italy Nucleic Acid Electrophoresis, by Instrument USD Million (2015-2020)
  • Table 80. Italy Nucleic Acid Electrophoresis, by Gel USD Million (2015-2020)
  • Table 81. United Kingdom Nucleic Acid Electrophoresis, by Application USD Million (2015-2020)
  • Table 82. United Kingdom Nucleic Acid Electrophoresis, by End Users USD Million (2015-2020)
  • Table 83. United Kingdom Nucleic Acid Electrophoresis, by Instrument USD Million (2015-2020)
  • Table 84. United Kingdom Nucleic Acid Electrophoresis, by Gel USD Million (2015-2020)
  • Table 85. Netherlands Nucleic Acid Electrophoresis, by Application USD Million (2015-2020)
  • Table 86. Netherlands Nucleic Acid Electrophoresis, by End Users USD Million (2015-2020)
  • Table 87. Netherlands Nucleic Acid Electrophoresis, by Instrument USD Million (2015-2020)
  • Table 88. Netherlands Nucleic Acid Electrophoresis, by Gel USD Million (2015-2020)
  • Table 89. Rest of Europe Nucleic Acid Electrophoresis, by Application USD Million (2015-2020)
  • Table 90. Rest of Europe Nucleic Acid Electrophoresis, by End Users USD Million (2015-2020)
  • Table 91. Rest of Europe Nucleic Acid Electrophoresis, by Instrument USD Million (2015-2020)
  • Table 92. Rest of Europe Nucleic Acid Electrophoresis, by Gel USD Million (2015-2020)
  • Table 93. MEA Nucleic Acid Electrophoresis, by Country USD Million (2015-2020)
  • Table 94. MEA Nucleic Acid Electrophoresis, by Application USD Million (2015-2020)
  • Table 95. MEA Nucleic Acid Electrophoresis, by End Users USD Million (2015-2020)
  • Table 96. MEA Nucleic Acid Electrophoresis, by Instrument USD Million (2015-2020)
  • Table 97. MEA Nucleic Acid Electrophoresis, by Gel USD Million (2015-2020)
  • Table 98. Middle East Nucleic Acid Electrophoresis, by Application USD Million (2015-2020)
  • Table 99. Middle East Nucleic Acid Electrophoresis, by End Users USD Million (2015-2020)
  • Table 100. Middle East Nucleic Acid Electrophoresis, by Instrument USD Million (2015-2020)
  • Table 101. Middle East Nucleic Acid Electrophoresis, by Gel USD Million (2015-2020)
  • Table 102. Africa Nucleic Acid Electrophoresis, by Application USD Million (2015-2020)
  • Table 103. Africa Nucleic Acid Electrophoresis, by End Users USD Million (2015-2020)
  • Table 104. Africa Nucleic Acid Electrophoresis, by Instrument USD Million (2015-2020)
  • Table 105. Africa Nucleic Acid Electrophoresis, by Gel USD Million (2015-2020)
  • Table 106. North America Nucleic Acid Electrophoresis, by Country USD Million (2015-2020)
  • Table 107. North America Nucleic Acid Electrophoresis, by Application USD Million (2015-2020)
  • Table 108. North America Nucleic Acid Electrophoresis, by End Users USD Million (2015-2020)
  • Table 109. North America Nucleic Acid Electrophoresis, by Instrument USD Million (2015-2020)
  • Table 110. North America Nucleic Acid Electrophoresis, by Gel USD Million (2015-2020)
  • Table 111. United States Nucleic Acid Electrophoresis, by Application USD Million (2015-2020)
  • Table 112. United States Nucleic Acid Electrophoresis, by End Users USD Million (2015-2020)
  • Table 113. United States Nucleic Acid Electrophoresis, by Instrument USD Million (2015-2020)
  • Table 114. United States Nucleic Acid Electrophoresis, by Gel USD Million (2015-2020)
  • Table 115. Canada Nucleic Acid Electrophoresis, by Application USD Million (2015-2020)
  • Table 116. Canada Nucleic Acid Electrophoresis, by End Users USD Million (2015-2020)
  • Table 117. Canada Nucleic Acid Electrophoresis, by Instrument USD Million (2015-2020)
  • Table 118. Canada Nucleic Acid Electrophoresis, by Gel USD Million (2015-2020)
  • Table 119. Mexico Nucleic Acid Electrophoresis, by Application USD Million (2015-2020)
  • Table 120. Mexico Nucleic Acid Electrophoresis, by End Users USD Million (2015-2020)
  • Table 121. Mexico Nucleic Acid Electrophoresis, by Instrument USD Million (2015-2020)
  • Table 122. Mexico Nucleic Acid Electrophoresis, by Gel USD Million (2015-2020)
  • Table 123. Company Basic Information, Sales Area and Its Competitors
  • Table 124. Company Basic Information, Sales Area and Its Competitors
  • Table 125. Company Basic Information, Sales Area and Its Competitors
  • Table 126. Company Basic Information, Sales Area and Its Competitors
  • Table 127. Company Basic Information, Sales Area and Its Competitors
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Nucleic Acid Electrophoresis: by Application(USD Million)
  • Table 134. Nucleic Acid Electrophoresis Research , by Region USD Million (2021-2026)
  • Table 135. Nucleic Acid Electrophoresis Diagnostics , by Region USD Million (2021-2026)
  • Table 136. Nucleic Acid Electrophoresis: by End Users(USD Million)
  • Table 137. Nucleic Acid Electrophoresis Research Institutes , by Region USD Million (2021-2026)
  • Table 138. Nucleic Acid Electrophoresis Hospitals , by Region USD Million (2021-2026)
  • Table 139. Nucleic Acid Electrophoresis Diagnostics Centre , by Region USD Million (2021-2026)
  • Table 140. Nucleic Acid Electrophoresis: by Instrument(USD Million)
  • Table 141. Nucleic Acid Electrophoresis Horizontal Gel Electrophoresis Systems , by Region USD Million (2021-2026)
  • Table 142. Nucleic Acid Electrophoresis Vertical Gel Electrophoresis Systems , by Region USD Million (2021-2026)
  • Table 143. Nucleic Acid Electrophoresis: by Gel(USD Million)
  • Table 144. Nucleic Acid Electrophoresis Polyacrylamide Gel , by Region USD Million (2021-2026)
  • Table 145. Nucleic Acid Electrophoresis Agarose Gel , by Region USD Million (2021-2026)
  • Table 146. South America Nucleic Acid Electrophoresis, by Country USD Million (2021-2026)
  • Table 147. South America Nucleic Acid Electrophoresis, by Application USD Million (2021-2026)
  • Table 148. South America Nucleic Acid Electrophoresis, by End Users USD Million (2021-2026)
  • Table 149. South America Nucleic Acid Electrophoresis, by Instrument USD Million (2021-2026)
  • Table 150. South America Nucleic Acid Electrophoresis, by Gel USD Million (2021-2026)
  • Table 151. Brazil Nucleic Acid Electrophoresis, by Application USD Million (2021-2026)
  • Table 152. Brazil Nucleic Acid Electrophoresis, by End Users USD Million (2021-2026)
  • Table 153. Brazil Nucleic Acid Electrophoresis, by Instrument USD Million (2021-2026)
  • Table 154. Brazil Nucleic Acid Electrophoresis, by Gel USD Million (2021-2026)
  • Table 155. Argentina Nucleic Acid Electrophoresis, by Application USD Million (2021-2026)
  • Table 156. Argentina Nucleic Acid Electrophoresis, by End Users USD Million (2021-2026)
  • Table 157. Argentina Nucleic Acid Electrophoresis, by Instrument USD Million (2021-2026)
  • Table 158. Argentina Nucleic Acid Electrophoresis, by Gel USD Million (2021-2026)
  • Table 159. Rest of South America Nucleic Acid Electrophoresis, by Application USD Million (2021-2026)
  • Table 160. Rest of South America Nucleic Acid Electrophoresis, by End Users USD Million (2021-2026)
  • Table 161. Rest of South America Nucleic Acid Electrophoresis, by Instrument USD Million (2021-2026)
  • Table 162. Rest of South America Nucleic Acid Electrophoresis, by Gel USD Million (2021-2026)
  • Table 163. Asia Pacific Nucleic Acid Electrophoresis, by Country USD Million (2021-2026)
  • Table 164. Asia Pacific Nucleic Acid Electrophoresis, by Application USD Million (2021-2026)
  • Table 165. Asia Pacific Nucleic Acid Electrophoresis, by End Users USD Million (2021-2026)
  • Table 166. Asia Pacific Nucleic Acid Electrophoresis, by Instrument USD Million (2021-2026)
  • Table 167. Asia Pacific Nucleic Acid Electrophoresis, by Gel USD Million (2021-2026)
  • Table 168. China Nucleic Acid Electrophoresis, by Application USD Million (2021-2026)
  • Table 169. China Nucleic Acid Electrophoresis, by End Users USD Million (2021-2026)
  • Table 170. China Nucleic Acid Electrophoresis, by Instrument USD Million (2021-2026)
  • Table 171. China Nucleic Acid Electrophoresis, by Gel USD Million (2021-2026)
  • Table 172. Japan Nucleic Acid Electrophoresis, by Application USD Million (2021-2026)
  • Table 173. Japan Nucleic Acid Electrophoresis, by End Users USD Million (2021-2026)
  • Table 174. Japan Nucleic Acid Electrophoresis, by Instrument USD Million (2021-2026)
  • Table 175. Japan Nucleic Acid Electrophoresis, by Gel USD Million (2021-2026)
  • Table 176. India Nucleic Acid Electrophoresis, by Application USD Million (2021-2026)
  • Table 177. India Nucleic Acid Electrophoresis, by End Users USD Million (2021-2026)
  • Table 178. India Nucleic Acid Electrophoresis, by Instrument USD Million (2021-2026)
  • Table 179. India Nucleic Acid Electrophoresis, by Gel USD Million (2021-2026)
  • Table 180. South Korea Nucleic Acid Electrophoresis, by Application USD Million (2021-2026)
  • Table 181. South Korea Nucleic Acid Electrophoresis, by End Users USD Million (2021-2026)
  • Table 182. South Korea Nucleic Acid Electrophoresis, by Instrument USD Million (2021-2026)
  • Table 183. South Korea Nucleic Acid Electrophoresis, by Gel USD Million (2021-2026)
  • Table 184. Taiwan Nucleic Acid Electrophoresis, by Application USD Million (2021-2026)
  • Table 185. Taiwan Nucleic Acid Electrophoresis, by End Users USD Million (2021-2026)
  • Table 186. Taiwan Nucleic Acid Electrophoresis, by Instrument USD Million (2021-2026)
  • Table 187. Taiwan Nucleic Acid Electrophoresis, by Gel USD Million (2021-2026)
  • Table 188. Australia Nucleic Acid Electrophoresis, by Application USD Million (2021-2026)
  • Table 189. Australia Nucleic Acid Electrophoresis, by End Users USD Million (2021-2026)
  • Table 190. Australia Nucleic Acid Electrophoresis, by Instrument USD Million (2021-2026)
  • Table 191. Australia Nucleic Acid Electrophoresis, by Gel USD Million (2021-2026)
  • Table 192. Rest of Asia-Pacific Nucleic Acid Electrophoresis, by Application USD Million (2021-2026)
  • Table 193. Rest of Asia-Pacific Nucleic Acid Electrophoresis, by End Users USD Million (2021-2026)
  • Table 194. Rest of Asia-Pacific Nucleic Acid Electrophoresis, by Instrument USD Million (2021-2026)
  • Table 195. Rest of Asia-Pacific Nucleic Acid Electrophoresis, by Gel USD Million (2021-2026)
  • Table 196. Europe Nucleic Acid Electrophoresis, by Country USD Million (2021-2026)
  • Table 197. Europe Nucleic Acid Electrophoresis, by Application USD Million (2021-2026)
  • Table 198. Europe Nucleic Acid Electrophoresis, by End Users USD Million (2021-2026)
  • Table 199. Europe Nucleic Acid Electrophoresis, by Instrument USD Million (2021-2026)
  • Table 200. Europe Nucleic Acid Electrophoresis, by Gel USD Million (2021-2026)
  • Table 201. Germany Nucleic Acid Electrophoresis, by Application USD Million (2021-2026)
  • Table 202. Germany Nucleic Acid Electrophoresis, by End Users USD Million (2021-2026)
  • Table 203. Germany Nucleic Acid Electrophoresis, by Instrument USD Million (2021-2026)
  • Table 204. Germany Nucleic Acid Electrophoresis, by Gel USD Million (2021-2026)
  • Table 205. France Nucleic Acid Electrophoresis, by Application USD Million (2021-2026)
  • Table 206. France Nucleic Acid Electrophoresis, by End Users USD Million (2021-2026)
  • Table 207. France Nucleic Acid Electrophoresis, by Instrument USD Million (2021-2026)
  • Table 208. France Nucleic Acid Electrophoresis, by Gel USD Million (2021-2026)
  • Table 209. Italy Nucleic Acid Electrophoresis, by Application USD Million (2021-2026)
  • Table 210. Italy Nucleic Acid Electrophoresis, by End Users USD Million (2021-2026)
  • Table 211. Italy Nucleic Acid Electrophoresis, by Instrument USD Million (2021-2026)
  • Table 212. Italy Nucleic Acid Electrophoresis, by Gel USD Million (2021-2026)
  • Table 213. United Kingdom Nucleic Acid Electrophoresis, by Application USD Million (2021-2026)
  • Table 214. United Kingdom Nucleic Acid Electrophoresis, by End Users USD Million (2021-2026)
  • Table 215. United Kingdom Nucleic Acid Electrophoresis, by Instrument USD Million (2021-2026)
  • Table 216. United Kingdom Nucleic Acid Electrophoresis, by Gel USD Million (2021-2026)
  • Table 217. Netherlands Nucleic Acid Electrophoresis, by Application USD Million (2021-2026)
  • Table 218. Netherlands Nucleic Acid Electrophoresis, by End Users USD Million (2021-2026)
  • Table 219. Netherlands Nucleic Acid Electrophoresis, by Instrument USD Million (2021-2026)
  • Table 220. Netherlands Nucleic Acid Electrophoresis, by Gel USD Million (2021-2026)
  • Table 221. Rest of Europe Nucleic Acid Electrophoresis, by Application USD Million (2021-2026)
  • Table 222. Rest of Europe Nucleic Acid Electrophoresis, by End Users USD Million (2021-2026)
  • Table 223. Rest of Europe Nucleic Acid Electrophoresis, by Instrument USD Million (2021-2026)
  • Table 224. Rest of Europe Nucleic Acid Electrophoresis, by Gel USD Million (2021-2026)
  • Table 225. MEA Nucleic Acid Electrophoresis, by Country USD Million (2021-2026)
  • Table 226. MEA Nucleic Acid Electrophoresis, by Application USD Million (2021-2026)
  • Table 227. MEA Nucleic Acid Electrophoresis, by End Users USD Million (2021-2026)
  • Table 228. MEA Nucleic Acid Electrophoresis, by Instrument USD Million (2021-2026)
  • Table 229. MEA Nucleic Acid Electrophoresis, by Gel USD Million (2021-2026)
  • Table 230. Middle East Nucleic Acid Electrophoresis, by Application USD Million (2021-2026)
  • Table 231. Middle East Nucleic Acid Electrophoresis, by End Users USD Million (2021-2026)
  • Table 232. Middle East Nucleic Acid Electrophoresis, by Instrument USD Million (2021-2026)
  • Table 233. Middle East Nucleic Acid Electrophoresis, by Gel USD Million (2021-2026)
  • Table 234. Africa Nucleic Acid Electrophoresis, by Application USD Million (2021-2026)
  • Table 235. Africa Nucleic Acid Electrophoresis, by End Users USD Million (2021-2026)
  • Table 236. Africa Nucleic Acid Electrophoresis, by Instrument USD Million (2021-2026)
  • Table 237. Africa Nucleic Acid Electrophoresis, by Gel USD Million (2021-2026)
  • Table 238. North America Nucleic Acid Electrophoresis, by Country USD Million (2021-2026)
  • Table 239. North America Nucleic Acid Electrophoresis, by Application USD Million (2021-2026)
  • Table 240. North America Nucleic Acid Electrophoresis, by End Users USD Million (2021-2026)
  • Table 241. North America Nucleic Acid Electrophoresis, by Instrument USD Million (2021-2026)
  • Table 242. North America Nucleic Acid Electrophoresis, by Gel USD Million (2021-2026)
  • Table 243. United States Nucleic Acid Electrophoresis, by Application USD Million (2021-2026)
  • Table 244. United States Nucleic Acid Electrophoresis, by End Users USD Million (2021-2026)
  • Table 245. United States Nucleic Acid Electrophoresis, by Instrument USD Million (2021-2026)
  • Table 246. United States Nucleic Acid Electrophoresis, by Gel USD Million (2021-2026)
  • Table 247. Canada Nucleic Acid Electrophoresis, by Application USD Million (2021-2026)
  • Table 248. Canada Nucleic Acid Electrophoresis, by End Users USD Million (2021-2026)
  • Table 249. Canada Nucleic Acid Electrophoresis, by Instrument USD Million (2021-2026)
  • Table 250. Canada Nucleic Acid Electrophoresis, by Gel USD Million (2021-2026)
  • Table 251. Mexico Nucleic Acid Electrophoresis, by Application USD Million (2021-2026)
  • Table 252. Mexico Nucleic Acid Electrophoresis, by End Users USD Million (2021-2026)
  • Table 253. Mexico Nucleic Acid Electrophoresis, by Instrument USD Million (2021-2026)
  • Table 254. Mexico Nucleic Acid Electrophoresis, by Gel USD Million (2021-2026)
  • Table 255. Research Programs/Design for This Report
  • Table 256. Key Data Information from Secondary Sources
  • Table 257. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Nucleic Acid Electrophoresis: by Application USD Million (2015-2020)
  • Figure 5. Global Nucleic Acid Electrophoresis: by End Users USD Million (2015-2020)
  • Figure 6. Global Nucleic Acid Electrophoresis: by Instrument USD Million (2015-2020)
  • Figure 7. Global Nucleic Acid Electrophoresis: by Gel USD Million (2015-2020)
  • Figure 8. South America Nucleic Acid Electrophoresis Share (%), by Country
  • Figure 9. Asia Pacific Nucleic Acid Electrophoresis Share (%), by Country
  • Figure 10. Europe Nucleic Acid Electrophoresis Share (%), by Country
  • Figure 11. MEA Nucleic Acid Electrophoresis Share (%), by Country
  • Figure 12. North America Nucleic Acid Electrophoresis Share (%), by Country
  • Figure 13. Global Nucleic Acid Electrophoresis share by Players 2020 (%)
  • Figure 14. Global Nucleic Acid Electrophoresis share by Players (Top 3) 2020(%)
  • Figure 15. Global Nucleic Acid Electrophoresis share by Players (Top 5) 2020(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Thermo Fisher Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 18. Thermo Fisher Scientific (United States) Revenue: by Geography 2020
  • Figure 19. Bio-Rad Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 20. Bio-Rad Laboratories (United States) Revenue: by Geography 2020
  • Figure 21. Merck Group (Germany) Revenue, Net Income and Gross profit
  • Figure 22. Merck Group (Germany) Revenue: by Geography 2020
  • Figure 23. Agilent Technologies (United States) Revenue, Net Income and Gross profit
  • Figure 24. Agilent Technologies (United States) Revenue: by Geography 2020
  • Figure 25. Danaher Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 26. Danaher Corporation (United States) Revenue: by Geography 2020
  • Figure 27. GE Healthcare (United States) Revenue, Net Income and Gross profit
  • Figure 28. GE Healthcare (United States) Revenue: by Geography 2020
  • Figure 29. QIAGEN N.V. (Netherlands) Revenue, Net Income and Gross profit
  • Figure 30. QIAGEN N.V. (Netherlands) Revenue: by Geography 2020
  • Figure 31. Harvard Bioscience (United States) Revenue, Net Income and Gross profit
  • Figure 32. Harvard Bioscience (United States) Revenue: by Geography 2020
  • Figure 33. Biomol GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 34. Biomol GmbH (Germany) Revenue: by Geography 2020
  • Figure 35. Agilent Technologies (United States) Revenue, Net Income and Gross profit
  • Figure 36. Agilent Technologies (United States) Revenue: by Geography 2020
  • Figure 37. Global Nucleic Acid Electrophoresis: by Application USD Million (2021-2026)
  • Figure 38. Global Nucleic Acid Electrophoresis: by End Users USD Million (2021-2026)
  • Figure 39. Global Nucleic Acid Electrophoresis: by Instrument USD Million (2021-2026)
  • Figure 40. Global Nucleic Acid Electrophoresis: by Gel USD Million (2021-2026)
  • Figure 41. South America Nucleic Acid Electrophoresis Share (%), by Country
  • Figure 42. Asia Pacific Nucleic Acid Electrophoresis Share (%), by Country
  • Figure 43. Europe Nucleic Acid Electrophoresis Share (%), by Country
  • Figure 44. MEA Nucleic Acid Electrophoresis Share (%), by Country
  • Figure 45. North America Nucleic Acid Electrophoresis Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Thermo Fisher Scientific (United States)
  • Bio-Rad Laboratories (United States)
  • Merck Group (Germany)
  • Agilent Technologies (United States)
  • Danaher Corporation (United States)
  • GE Healthcare (United States)
  • QIAGEN N.V. (Netherlands)
  • Harvard Bioscience (United States)
  • Biomol GmbH (Germany)
  • Agilent Technologies (United States)
Additional players considered in the study are as follows:
Beckman Coulter (United States) , Cleaver Scientific (United Kingdom) , Hoefer (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation